Future Market Insights3d
MEA Biologics and Biosimilar Market to Reach USD 875.6 Million by 2033, Fueled by Rising Adoption of Adalimumab | FMI
Abbott Operations Uruguay S.R.L. and Shanghai Henlius Biotech, Inc. entered into a semi-exclusive licensing agreement in May ...
Shanghai Henlius Biotech Announces Merger Vote
Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended ...
Shanghai Fosun Pharmaceutical Advances Henlius Merger Plans
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks ...
Business Insider4d
Shanghai Henlius Biotech to Vote on Major Merger
Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter ...
Business Insider4d
Shanghai Henlius Biotech Moves Toward Privatization
Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter ...
Palleon and Shanghai Henlius Biotech link on autoimmune therapy
Palleon Pharmaceuticals and Shanghai Henlius Biotech have entered a licence agreement and partnership for the former’s ...
ENDPOINTS NEWS6d
Gilead deep­ens its stake in As­sem­bly Bio­sciences; NGM li­cens­es out MASH drug
Plus, news about Abilita Therapeutics, Orion, Novartis, XGEN Venture, Palleon, Henlius, TigaTx, HERVolution Therapeutics and Krystal Biotech: ...
Le Lézard6d
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management
Fennec Pharmaceuticals Inc. , a specialty pharmaceutical company, today announced the early repayment of $13 million of the Company's approximately $32 million outstanding convertible debt facility ...
Le Lézard6d
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
COTA Inc., a leader in real-world data (RWD) and analytics for oncology, announces a new partnership with leading precision oncology company Guardant Health Inc. that will allow biopharmaceutical ...
Le Lézard6d
Palleon Pharmaceuticals and Henlius Collaborate to Advance Glycan Editing as a Treatment for Autoimmune Diseases
Palleon Pharmaceuticals, a company pioneering glyco-immunology drug development to treat autoimmune diseases and cancer, today announced a collaboration and license agreement with Shanghai Henlius ...
Le Lézard6d
Ampion Brings Clean Energy, Savings to Mainers with 5 New Community Solar Sites
Five Maine community solar sites managed by Ampion Renewable Energy, a leading community solar subscription management company, reached commercial operation and started producing clean energy in ...
Le Lézard6d
Dr. Rajan Bhatt Named CEO of OrthoArizona
OrthoArizona, one of the nation's largest privately-held orthopedic groups, today announced the appointment of Dr. Rajan Bhatt as Chief Executive Officer. Bhatt brings a unique combination of medical ...